Published Date:2023-06-28 Original Link:https://www.onenessbio.com/en/news_detail230_3.htm No 2 Date of announcement 2023/06/29 Time of announcement  00:14:40 Subject SNS812, a broad-spectrum siRNA co-developed by Oneness and Microbio (Shanghai) to treat SARS-CoV-2 infection, was greenlighted by TFDA to proceed with a Ph2 study To which item it meets paragraph 10 Date of events 2023/06/28 Statement Product:SNS812, a broad-spectrum siRNA...Read More

Published Date:2023-06-28 Original Link:https://www.onenessbio.com/en/news_detail229_3.htm No 1 Date of announcement 2023/06/28 Time of announcement 18:48:09 Subject Oneness Biotech Co., Ltd. receives a Vietnamese patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2023/06/28 Statement Date of occurrence of the event:2023/06/28 Company...Read More